TLK1-IN-1 (Compound 5n) is a TLK1 inhibitor with an IC50 of 7.2 µM against TLK1B and a GI50 of 2.7 µM in LNCaP cells. TLK1-IN-1 induces DNA damage and apoptosis in cancer cells, making it a potential candidate for prostate cancer research[1].
Molecular Weight:
544.83
Formula:
C24H23BrClN5O3
Target:
Ser/Thr Kinase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
